Literature DB >> 33611616

Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis.

Ursula Schwab1,2, Andrew N Reynolds3, Taisa Sallinen1, Angela Albarosa Rivellese4, Ulf Risérus5.   

Abstract

PURPOSE: Advice regarding the intake of dietary fats is particularly relevant to those with type 2 diabetes, given their increased risk of cardiovascular disease.
METHODS: We have undertaken a systematic review of fat intakes and cardiovascular disease risk in adults with type 2 diabetes using an online search strategy to 24 April 2020, augmented with hand searching. Searches, extraction, and risk of bias assessments were undertaken by two researchers. The quality of evidence was assessed with GRADE protocols.
RESULTS: We identified five eligible prospective studies of 22,591 participants followed for on average 9.8 years, and one trial of 14 participants with type 2 diabetes. Limited data were available; however, replacement analyses of saturated fat with polyunsaturated fat (RR for 2% energy replacement 0.87 95% CI: 0.77-0.99) or carbohydrate (RR for 5% energy replacement 0.82 95% CI: 0.67-1.00) was associated with reduced cardiovascular disease occurrence. Higher polyunsaturated: saturated fat intake was also associated with reduced cardiovascular disease occurrence (RR 0.75 95% CI: 0.57-0.98). The quality of evidence was low to very-low.
CONCLUSION: Although only limited data were available, replacement of saturated fats with other macronutrients, such as polyunsaturated fats, was associated with reduced cardiovascular disease occurrence. Supporting evidence from research in the general population increases confidence in these findings. Until more data are available to better comment on dietary fat intakes in cardiovascular disease risk of those with type 2 diabetes, it appears appropriate that saturated fats be replaced in the diet with other macronutrients, such as polyunsaturated fats.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Cardiovascular disease; Diabetes management; Dietary fats; Lifestyle modification; Nutrition therapy

Year:  2021        PMID: 33611616     DOI: 10.1007/s00394-021-02507-1

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  9 in total

1.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

Authors:  Aidin Rawshani; Araz Rawshani; Stefan Franzén; Björn Eliasson; Ann-Marie Svensson; Mervete Miftaraj; Darren K McGuire; Naveed Sattar; Annika Rosengren; Soffia Gudbjörnsdottir
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

2.  WHO draft guidelines on dietary saturated and trans fatty acids: time for a new approach?

Authors:  Arne Astrup; Hanne Cs Bertram; Jean-Philippe Bonjour; Lisette Cp de Groot; Marcia C de Oliveira Otto; Emma L Feeney; Manohar L Garg; Ian Givens; Frans J Kok; Ronald M Krauss; Benoît Lamarche; Jean-Michel Lecerf; Philippe Legrand; Michelle McKinley; Renata Micha; Marie-Caroline Michalski; Dariush Mozaffarian; Sabita S Soedamah-Muthu
Journal:  BMJ       Date:  2019-07-03

Review 3.  Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases.

Authors:  Matthias B Schulze; Anne Marie Minihane; Rasha Noureldin M Saleh; Ulf Risérus
Journal:  Lancet Diabetes Endocrinol       Date:  2020-09-16       Impact factor: 32.069

4.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

5.  Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Authors:  Kausik K Ray; Helen M Colhoun; Michael Szarek; Marie Baccara-Dinet; Deepak L Bhatt; Vera A Bittner; Andrzej J Budaj; Rafael Diaz; Shaun G Goodman; Corinne Hanotin; Robert A Harrington; J Wouter Jukema; Virginie Loizeau; Renato D Lopes; Angèle Moryusef; Jan Murin; Robert Pordy; Arsen D Ristic; Matthew T Roe; José Tuñón; Harvey D White; Andreas M Zeiher; Gregory G Schwartz; Philippe Gabriel Steg
Journal:  Lancet Diabetes Endocrinol       Date:  2019-07-01       Impact factor: 32.069

Review 6.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Authors:  Michael G Silverman; Brian A Ference; Kyungah Im; Stephen D Wiviott; Robert P Giugliano; Scott M Grundy; Eugene Braunwald; Marc S Sabatine
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

7.  The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients.

Authors:  Marjo J Campmans-Kuijpers; Ivonne Sluijs; Ute Nöthlings; Heinz Freisling; Kim Overvad; Heiner Boeing; Giovanna Masala; Salvatore Panico; Rosario Tumino; Sabina Sieri; Ingegerd Johansson; Anna Winkvist; Verena A Katzke; Tilman Kuehn; Peter M Nilsson; Jytte Halkjær; Anne Tjønneland; Annemieke M Spijkerman; Larraitz Arriola; Carlotta Sacerdote; Aurelio Barricarte; Anne M May; Joline W Beulens
Journal:  Clin Nutr       Date:  2015-08-28       Impact factor: 7.324

8.  Reduction in saturated fat intake for cardiovascular disease.

Authors:  Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid
Journal:  Cochrane Database Syst Rev       Date:  2020-08-21

9.  Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.

Authors:  Jingjing Jiao; Gang Liu; Hyun Joon Shin; Frank B Hu; Eric B Rimm; Kathryn M Rexrode; JoAnn E Manson; Geng Zong; Qi Sun
Journal:  BMJ       Date:  2019-07-02
  9 in total
  2 in total

1.  Impact of Extensively Hydrolyzed Infant Formula on Circulating Lipids During Early Life.

Authors:  Santosh Lamichhane; Heli Siljander; Marja Salonen; Terhi Ruohtula; Suvi M Virtanen; Jorma Ilonen; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič
Journal:  Front Nutr       Date:  2022-05-24

2.  Evidence for Beneficial Associations between Isoenergetic Macronutrient Exchanges and Serum non-HDL Cholesterol, a Measure of All Circulating Atherogenic, apoB-Containing Lipoproteins.

Authors:  Bruce A Griffin; Julie A Lovegrove
Journal:  J Nutr       Date:  2021-08-07       Impact factor: 4.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.